|
Volumn 148, Issue 7, 2008, Pages 567-
|
Response to sunitinib in medullary thyroid cancer
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITONIN;
CARCINOEMBRYONIC ANTIGEN;
OCTREOTIDE;
PROTEIN RET;
SUNITINIB;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
PYRROLE DERIVATIVE;
RET PROTEIN, HUMAN;
UNCLASSIFIED DRUG;
AGED;
CALCITONIN BLOOD LEVEL;
CASE REPORT;
CELL HYPERPLASIA;
CERVICAL LYMPH NODE;
COMPUTER ASSISTED TOMOGRAPHY;
DIARRHEA;
FAMILY HISTORY;
FEMALE;
GENE MUTATION;
HUMAN;
LETTER;
LUNG METASTASIS;
LYMPHADENOPATHY;
MEDULLARY CARCINOMA;
MEDULLARY THYROID CANCER;
MULTIPLE CYCLE TREATMENT;
MULTIPLE ENDOCRINE NEOPLASIA;
NECK DISSECTION;
POINT MUTATION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTO ONCOGENE;
THYROID CANCER;
THYROIDECTOMY;
TREATMENT DURATION;
TREATMENT RESPONSE;
TUMOR VOLUME;
DRUG ANTAGONISM;
THYROID TUMOR;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, MEDULLARY;
FEMALE;
HUMANS;
INDOLES;
PROTO-ONCOGENE PROTEINS C-RET;
PYRROLES;
THYROID NEOPLASMS;
|
EID: 42249088434
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-7-200804010-00027 Document Type: Letter |
Times cited : (35)
|
References (5)
|